Atlas Trials

Reslizumab in Patients With Severe Asthma Who Failed to Respond to Omalizumab

Clinical trial NCT03074942 · COMPLETED

Trial details

NCT number
NCT03074942
Sponsor
Sociedad Española de Neumología y Cirugía Torácica
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Severe Asthma
Start date
2017-04-20
Primary completion
2018-03-26
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.